← back to search

Xavier Leroy

Université Claude Bernard Lyon 1 · FR
Area of research
Artificial Intelligence · Computational Theory and Mathematics
Research interest
Research interests include Medicine, Pathology, Renal cell carcinoma, Cancer research, Prostate cancer, and Tuberous sclerosis.
h-index
citations
1,060
works
11
NIH funding
primary concept
email

Recent publications

Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors
Nature Cancer 2021cited by 78position: middledoi
Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients
Modern Pathology 2021cited by 47position: middledoi
Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases
European Journal of Surgical Oncology 2020cited by 33position: middledoi
Lack of resolution sensor drives age-related cardiometabolic and cardiorenal defects and impedes inflammation-resolution in heart failure
Molecular Metabolism 2019cited by 69position: middledoi
TMPRSS2:ERG gene fusion expression regulates bone markers and enhances the osteoblastic phenotype of prostate cancer bone metastases
Cancer Letters 2018cited by 65position: middledoi
Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC)
The American Journal of Surgical Pathology 2017cited by 149position: middledoi
Partial Prostatectomy for Anterior Cancer: Short-term Oncologic and Functional Outcomes
European Urology 2016cited by 54position: middledoi
Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone
Oncotarget 2016cited by 27position: middledoi
Tuberous Sclerosis–associated Renal Cell Carcinoma
The American Journal of Surgical Pathology 2014cited by 294position: middledoi
Program Logics for Certified Compilers
Cambridge University Press eBooks 2014cited by 169position: lastdoi
PLA2R1 Mediates Tumor Suppression by Activating JAK2
Cancer Research 2013cited by 75position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Martine Duterque‐Coquillaud · Institut Pasteur2 papers (2016–2018)Edith Bonnelye · Université Claude Bernard Lyon 12 papers (2016–2018)Yvan de Launoit · Université Claude Bernard Lyon 12 papers (2013–2018)Anaïs Fradet · Université Claude Bernard Lyon 12 papers (2016–2018)Kiril Trpkov · University of Calgary2 papers (2014–2017) · 2 papers (2016–2018)Anthony J. Gill · The University of Sydney2 papers (2014–2017)Mathilde Bouchet · Université Claude Bernard Lyon 12 papers (2016–2018)Adeboye O. Osunkoya · Emory University2 papers (2014–2017)Philippe Clézardin · Université Claude Bernard Lyon 12 papers (2016–2018)Arnauld Villers · Institut Paoli-Calmettes2 papers (2016–2018)Jesse K. McKenney · Cleveland Clinic2 papers (2014–2017) · 1 papers (2018–2018)Stéphanie Verbeke · Université Claude Bernard Lyon 11 papers (2013–2013)Rohit Mehra · University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center1 papers (2014–2014)Benjamin Le Calvé · Université Claude Bernard Lyon 11 papers (2013–2013)Éva Compérat · University of Vienna1 papers (2017–2017)Delphine Gitenay · Université Claude Bernard Lyon 11 papers (2013–2013) · 1 papers (2018–2018)Paul C. Norris · Boston Scientific (United States)1 papers (2019–2019)